Allscripts (MDRX) Tops Q3 EPS by 5c; Withdrawing Guidance; to Evaluate Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Equities turn higher as Treasury yields drop from highs
- Fed’s Jefferson sees no urgency for another rate increase
- Oil prices rise $3 after China suspends fuel exports
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Anthropic targets mid-November for public debut - report
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
Piper Jaffray Downgrades Allscripts (MDRX) to Underweight
November 9, 2012 6:54 AM ESTPiper Jaffray downgraded Allscripts (NASDAQ: MDRX) from Neutral to Underweight with a price target of $7.00 (from $12.00) following Q3 results and announcement that it will explore alternatives.
For an analyst ratings summary and ratings history on Allscripts... More
Allscripts-Misys (MDRX) Resumes, Shares Higher in Late Trading
November 8, 2012 4:40 PM ESTAllscripts-Misys Healthcare Solution (NASDAQ: MDRX) resumes trading with the stock up over 7 percent in the late session Thursday.... More
Allscripts-Misys Healthcare Solution (MDRX) halted, news pending
November 8, 2012 4:02 PM ESTAllscripts-Misys Healthcare Solution (NASDAQ: MDRX) halted, news pending... More
